Kickstart your portfolio with a U.S. stock on us
Sign up and fund a new Wall St account and get a full U.S. share.Sign up and fund a new Wall St account and get a full share randomly chosen between GoPro, Dropbox or Nike.T&Cs apply
Pliant Therapeutics Inc
About PLRX
Pliant Therapeutics, Inc. is a late-stage biotechnology company, which is focused on discovering and developing novel therapies for the treatment of fibrosis and related diseases. The Company’s lead product candidate, bexotegrast (PLN-74809), is an oral, small molecule, dual selective inhibitor of avb6 and avb1 integrins that is in development in the lead indication for the treatment of idiopathic pulmonary fibrosis, or idiopathic pulmonary fibrosis (IPF). The Company’s second clinical program, PLN-101095, is a small molecule, dual selective inhibitor of integrins avb8 and avb1 for the treatment of solid tumors that are resistant to immune checkpoint inhibitors. Its Phase 1-ready program PLN-101325, is in development for treatment of muscular dystrophies, including Duchenne muscular dystrophy. PLN-101325 is a monoclonal antibody designed to act as an allosteric agonist of integrin a7b1.
Find out what a historical investment in Pliant Therapeutics Inc would be worth today using our PLRX stock calculator.
Market Capitalisation
$71.21M
Price-earnings ratio
-
Dividend yield
0.00%
Volume
184
High today
$1.20
Low today
$1.13
Open price
$0.00
52-week high
$1.95
52-week low
$1.09
Ready to start your investing journey with Stake?
Open an accountHow do I buy PLRX shares in Australia?
Buying PLRX shares in Australia can be done through an online investing platform, such as Stake. Follow the simple steps below to start investing in Pliant Therapeutics Inc in minutes.
- Sign up with some I.D. and zero paperwork
- Add funds to your account
- Make your first investment in PLRX
What is the ticker symbol of Pliant Therapeutics Inc?
The ticker symbol for Pliant Therapeutics Inc is PLRX.
How much is one share of PLRX?
One share of PLRX is valued at $1.19 as of 10 June 2026.
What is the market capitalisation of Pliant Therapeutics Inc PLRX?
As of 10 June 2026 Pliant Therapeutics Inc has a market cap of $71.21M.
What is the 52-week high for Pliant Therapeutics Inc stock?
The Pliant Therapeutics Inc 52-week high stock price is $1.95.
What is the 52-week low for Pliant Therapeutics Inc stock?
The Pliant Therapeutics Inc 52-week low stock price is $1.09.
Can I buy PLRX shares through Stake, an investing platform like CommSec, Selfwealth or Superhero?
Yes, the Stake investing platform allows you to buy PLRX shares and over 12,000 more stocks and ETFs across the ASX and Wall St.
This is not financial product advice nor a recommendation to invest in the securities listed. Past performance is not a reliable indicator of future performance. As always, do your own research and consider seeking financial, legal and taxation advice before investing. No representation is made as to the timeliness, reliability, accuracy or completeness of the market data provided.
Invest in PLRX on Stake
- Buy PLRX from US$3 brokerage
- Invest in 9,500+ U.S. stocks and ETFs
- Own a slice of PLRX from only US$10 with fractional shares
Stock shown for demonstrative purposes only. US$3 brokerage up to US$30,000.
PLRX related stocks